The Global Intradermal Injection Industry is poised for unprecedented growth, with an anticipated valuation of over US$ 3,878 Million in 2022, soaring to new heights with a projected compound annual growth rate (CAGR) of 10.8% from 2022 to 2032, according to the latest report from Future Market Insights (FMI).
Recent technological advancements have ushered in a new era of surgical approaches, focusing on minimizing waste and optimizing results. One notable development is the emergence of reusable intradermal devices, contributing to reduced waste generation and positively impacting overall economic productivity.
The use of intradermal delivery systems has gained prominence, supported by compelling evidence from various meta-analyses showcasing a notable reduction in the intensity of adverse events associated with drug administration. This paves the way for a robust and sustainable market growth trajectory in the foreseeable future.
This is one of the major factors that act as one of the leading reasons for increasing the Global Intradermal Injection Industry size of tuberculin syringes. According to the American Cancer Society’s 2022 report, over 1.9 million new cancers are expected to be recorded in the United States in 2022. Also, as per the same source, the risk of having cancer rises dramatically as one gets older, and in the United States, 80% of cancer patients are 55 or older, with 57% being 65 or older. These figures tell that the growing geriatric population is expected to have a significant positive impact on the growth of the market.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15855
Key Takeaways from the Global Intradermal Injection Industry Study
- The global Intradermal Injection market is expected to garner a market value of US$ 10,814.47 Million.
- Market is projected to exhibit a compound annual growth rate (CAGR) of 10.8% from 2022 to 2032.
- The Europe Intradermal Injection market size is anticipated to register commendable growth, with the United Kingdom acquiring a major share.
- North America was the leading regional segment in terms of revenue and market share.
- Based on method, the normal sized needles dominate the market.
By application, the tuberculin skin test segment is estimated to hold the largest share.
“The growing burden of chronic diseases has led to a rise in the overall use of syringes, particularly disposable syringes, intradermal jet injectors, microinjections, and ballistic intradermal injections treatment and diagnostic purposes,” says an analyst at Future Market Insights.
Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15855
Key Market Players
Major players are channeling efforts toward expanding their production capacities to strengthen their market share and cater to the growing demand. Market expansion is anticipated to be aided by the growing number of partnerships and collaborations among key players who are looking to increase their presence in the market. Key players in the Global Intradermal Injection Industry are Becton Dickinson, Cardinal Health, West Pharmaceuticals Services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, and Hindustan Syringes and Medical Devices.
In May 2022, Stevanato Group S.p.A. signed an exclusive agreement with leading medical device developer and manufacturer Owen Mumford Ltd. for its Aidaptus auto-injector. Adeptus is a 2-step, single-use auto-injector with a versatile design that accommodates both 1 mL and 2.25 mL prefilled glass syringes in the same base device.
In May 2020, Takeda Pharmaceutical Company Limited received approval from the European Commission for the subcutaneous (SC) formulation of Entyvio (vedolizumab), a gut-selective biologic for use as maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD). Entyvio SC is available in both a pre-filled syringe and a pre-filled pen.
Terumo Corporation is a pioneer in hypodermic needle innovation. The company offers a comprehensive platform of precision-engineered needle and needle stick prevention technologies ready for the most challenging applications and high-throughput processing environments. The company helps design and deliver safer, less painful injections to ensure the therapeutic success of the drug product. Some of its products include the Nanopass® 34G Needle for Pen Injectors, the Neolus Needles, SurGuard® Safety Hypodermic Needles, the SurGuard® 3 Safety Hypodermic Needles, and the Terumo 3-Part Syringe.
In May 2021, Crossject announced further strengthening of its partnership with long-term collaborator Cenexi to ramp-up industrial-scale manufacturing of the ZENEO® needle-free auto-injection. With this announcement, Cenexi strengthened its positioning on innovation and sterile manufacturing expertise thanks to its human-scale agility and its recognized skills in pharmaceutical development.
More Valuable Insights
- In its new offering, Future Market Insights presents an unbiased analysis of the Global Intradermal Injection Industry, presenting a historical analysis from 2017 to 2021 and forecast statistics for 2022-2032.
- The study reveals essential insights based on Method (normal-sized needles, Short Needle (Intradermal Microinjection, Microneedle Arrays, and Tattoo Devices], and Without Needle {Intradermal Liquid Jet Devices and Ballistic Intradermal Injectors]), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), and End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others) & Region.
Buy a Complete Research Report
https://www.futuremarketinsights.com/checkout/15855
About the Technology at Future Market Insights
The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.
Key Segments Profiled in the Global Intradermal Injection Industry Industry Survey
Global Intradermal Injection Industry by Method:
- Normal Sized Needles
- Short Needle
- Intradermal Microinjection
- Microneedle Arrays
- Tattoo Devices
- Without Needle
- Intradermal Liquid Jet Devices and
Ballistic Intradermal Injectors
Global Intradermal Injection Industry by Application:
- Tuberculin Skin Test
- Allergy Test
- Local Aesthetics
- Others
Global Intradermal Injection Industry by End User:
- Hospitals
- Diagnostic Laboratories
- Academics and Research Institutes
- Others
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
